South & Central America Carboxy Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Tabletop, Portable, and Others), Application, and End User (Hospitals, Aesthetic Clinics, and Wellness Center)

List of Tables

The South & Central America carboxy therapy market is expected to grow from US$ 6.78 million in 2022 to US$ 13.66 million by 2028. It is estimated to grow at a CAGR of 12.4% from 2022 to 2028.

Growing Uptake of Noninvasive Aesthetic Procedures is Driving the South & Central America Carboxy Therapy Market

The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an essential aspect of strengthening healthcare systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with available resources. Minimally invasive surgeries (MIS) and non-invasive procedures are among the approaches that result in low waste generation and reduced medical expenses. Moreover, these procedures ensure low absenteeism at the workplace, which has a net positive effect on the productivity of an economy. Minimal invasiveness results in faster recovery, lesser scarring, limited stress, and better patient satisfaction. The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in procedures, such as skin relaxation, surface renewal, and skin tightening, depending on the specific patient's needs. Since the appearance of the skin is considered an essential factor in wellbeing and health, the number of aesthetic procedures performed is increasing steadily. Further, nonsurgical procedures include facial injections, which help correct facial lines, wrinkles, cellulite reduction, and unwanted fat reduction with minimal side effects. The International Society of Aesthetic Plastic Surgery (ISAPS) defines a nonsurgical cosmetic procedure as an effective and safe procedure for those who are willing to undergo subtle enhancement and surgical result enhancement with lower recovery periods; these procedures often do not require extensive training, unlike surgical procedures that are associated with greater risks. Thus, the surge in the uptake of minimally invasive and noninvasive aesthetic procedures is driving the South & Central America carboxy therapy market t.

South & Central America Carboxy Therapy Market Overview

The South & Central America carboxy therapy market is segmented into Brazil, Argentina, and South & Central America. Brazil has the sixth-largest GDP in the world, the fourth-highest population among the countries listed, and a fairly high growth rate of the over 60s over the next 15 years, suggesting a huge market potential for healthcare products and services. Brazil has a high number of plastic surgeries. It is one of the countries where this type of procedure is most widely practiced. With a very open-minded customer base, cosmetic surgery is booming in Brazil. According to statistics published by the International Society of Aesthetic Plastic Surgery (ISAPS), Brazilian plastic surgeons performed 1,929,359 cosmetic procedures in 2020. After the US, Brazil ranked second for the most cosmetic procedures in 2020. The impressive number of Brazilian cosmetic procedures underscores a profitable market that attracts business opportunities into this country, promoting the growth of the carboxy therapy market. The market for carboxy therapy in Brazil has grown rapidly in recent years. According to the 2020 International Society of Aesthetic Plastic Surgery report, Brazil had a total of 45,342 face rejuvenation procedures, which increased the use of carboxy therapy to deal with the signs of aging. As per Agencia IBGE Noticias 2022 report, the aging population in Brazil was 31.2 million by the end of 2021, which has experienced an increase of 39.8% since 2012.

South & Central America Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Carboxy Therapy Market Segmentation

The South & Central America carboxy therapy market is segmented into type, application, end user, and country.

Based on type, the South & Central America carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment is expected to hold the largest market share by 2022.

Based on application, the South & Central America carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rheumatology, sports medicine, and others. The aesthetic medicine segment is expected to hold the largest market share by 2022. The aesthetic medicine segment is subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles.

Based on end user, the South & Central America carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment is expected to hold the largest market share by 2022.

Based on country, the South & Central America carboxy therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022.

Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; and Mezopharma are among the leading companies operating in the South & Central America carboxy therapy market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America carboxy therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America carboxy therapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the carboxy therapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00028000

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Carboxy Therapy Market - By Type
- 1.3.2 SAM Carboxy Therapy Market - By Application
- 1.3.3 SAM Carboxy Therapy Market - By End User
- 1.3.4 SAM Carboxy Therapy Market - By Country

2. Carboxy Therapy Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Carboxy Therapy Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion

5. SAM Carboxy Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing Uptake of Non-invasive Aesthetic Procedures
- 5.1.2 Increasing Demand for Anti-aging Treatments Along with Surge in Geriatric Population
5.2 Market Restraints
- 5.2.1 Regulatory Policies and Safety Concerns Associated with Carbon Therapy
5.3 Market Opportunities
- 5.3.1 Untapped Potential of Emerging Economies
5.4 Future Trends
- 5.4.1 Increase in Application Areas
5.5 Impact Analysis

6. Carboxy Therapy Market- SAM Analysis

6.1 SAM Carboxy Therapy Market Revenue Forecast and Analysis

7. SAM Carboxy Therapy Market Analysis - By Type

7.1 Overview
7.2 SAM Carboxy Therapy Market Revenue Share, by Type (2021 & 2028)
7.3 Tabletop
- 7.3.1 Overview
- 7.3.2 Tabletop: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Portable
- 7.4.1 Overview
- 7.4.2 Portable: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)

8. SAM Carboxy Therapy Market Analysis - By Application

8.1 Overview
8.2 SAM Carboxy Therapy Market Revenue Share, by Application (2021 & 2028)
8.3 Aesthetic Medicine
- 8.3.1 Overview
- 8.3.2 Aesthetic Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Cellulite
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Cellulite: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Stretch Marks
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Stretch Marks: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Alopecia
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Alopecia: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.4 Dark Under-Eye Circles
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Dark Under-Eye Circles: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Dermatology
- 8.4.1 Overview
- 8.4.2 Dermatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Gynecology
- 8.5.1 Overview
- 8.5.2 Gynecology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Angiology
- 8.6.1 Overview
- 8.6.2 Angiology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.7 Orthopedics and Rheumatology
- 8.7.1 Overview
- 8.7.2 Orthopedics and Rheumatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.8 Sports Medicine
- 8.8.1 Overview
- 8.8.2 Sports Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)

9. SAM Carboxy Therapy Market - By End User

9.1 Overview
9.2 SAM Carboxy Therapy Market, by End User, 2021 and 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Aesthetic Clinics
- 9.4.1 Overview
- 9.4.2 Aesthetic Clinics: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Wellness Center
- 9.5.1 Overview
- 9.5.2 Wellness Center: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)

10. SAM Carboxy Therapy Market - by Country Analysis

10.1 Overview
- 10.1.1 South & Central America: Carboxy Therapy Market, by Country, 2021 & 2028 (%)
  - 10.1.1.1 Brazil: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Brazil: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.1.3 Brazil: Carboxy Therapy Market, by Type, 2019-2028 (US$ 'Million)
    - 10.1.1.1.4 Brazil: Carboxy Therapy Market, by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.1.4.1 Brazil: Carboxy Therapy Market, For Aesthetic Medicine by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.1.5 Brazil: Carboxy Therapy Market, by End User, 2019-2028 (US$ 'Million)
  - 10.1.1.2 Argentina: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Argentina: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.2.3 Argentina: Carboxy Therapy Market, by Type, 2019-2028 (US$ 'Million)
    - 10.1.1.2.4 Argentina: Carboxy Therapy Market, by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.2.4.1 Argentina: Carboxy Therapy Market, For Aesthetic Medicine by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.2.5 Argentina: Carboxy Therapy Market, by End User, 2019-2028 (US$ 'Million)
  - 10.1.1.3 Rest of South & Central America: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Rest of South & Central America: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 10.1.1.3.3 Rest of South & Central America: Carboxy Therapy Market, by Type, 2019-2028 (US$ 'Million)
    - 10.1.1.3.4 Rest of South & Central America: Carboxy Therapy Market, by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.3.4.1 Rest of South & Central America: Carboxy Therapy Market, For Aesthetic Medicine by Application, 2019-2028 (US$ 'Million)
    - 10.1.1.3.5 Rest of South & Central America: Carboxy Therapy Market, by End User, 2019-2028 (US$ 'Million)

11. Industry Landscape

11.1 Overview
11.2 Developments
- 11.2.1 Overview

12. Company Profiles

12.1 DTA Medical
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Carbossiterapia Italiana
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Kastner-Praxisbedarf
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Mezopharma
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 MBE Medical Division
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms, Carboxy Therapy Market